Eli Lilly forays into dermatological space with launch of psoriasis drug

Eli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically target a protein that plays a role in triggering and maintaining inflammation in psoriasis. Copellor is a prescription medicine that is only to be used on the advice of a dermatologist or rheumatologist and under medical supervision.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Zk6zEy4
via IFTTT